Docetaxel

Catalog No.S1148 Synonyms: RP56976, NSC 628503

Molecular Weight(MW): 807.88

Docetaxel, an analog of paclitaxel, is an inhibitor of depolymerisation of microtubules by binding to stabilized microtubules.

6 Customer Reviews

Viability of cells after exposure to 0, 10, or 10,000 nM docetaxel, assessed by calcein-AM staining (green, left panels) and ethidium homodimer-1 (red, middle panels).

Mol Pharmaceutics, 2014, 11: 2040−50. Docetaxel purchased from Selleck.

J Transl Med 2013 0.6. Docetaxel purchased from Selleck.
J Transl Med 2013 0.6. Docetaxel purchased from Selleck.

TNBC and non-TNBC cells were treated for 6 d with the specified concentrations of docetaxel (doc) alone, TTK inhibitor (TTKi) alone or the combinations. The survival of cells was measured using the MTS/MTA assay. ***P<0.001 comparing the combination with single agents and with non-TNBC cell lines.

Oncogenesis, 2014, 3: e100 . Docetaxel purchased from Selleck.
Cell cycle study of percent cell populations in various phases after treatment with vehicle, HCI-2509 in increasing concentrations and docetaxel alone and in combination with HCI-2509 using (a) PC3 cells. Student's unpaired t-tests, using GraphPad Prism software, were used to calculate two-tailed P-values for each experiment to determine statistical significance between untreated and treated samples. The statistically significant P-values are labeled in each figure with an asterisk. (Replicated two more times, representative graph shown).

Prostate Cancer Prostatic Dis, 2016, 19(4):349-357. Docetaxel purchased from Selleck.

Biomed Pharmacother, 2018, 99:445-450. Docetaxel purchased from Selleck.

Purity & Quality Control

Choose Selective Microtubule Associated Inhibitors

Biological Activity

Description

Docetaxel, an analog of paclitaxel, is an inhibitor of depolymerisation of microtubules by binding to stabilized microtubules.

Targets

Microtubules ^[1]
(Cell-free assay)

In vitro

Docetaxel is a cytotoxic agent, especially for proliferating cells, which is related to its ability to promote the formation of microtubule bundles and induce sustained mitotic arrest, followed by apoptosis of mitotically arrested cells or permanent mitotic block. Docetaxel suppresses microtubule dynamic instability as well as tread-milling, resulting in the failure of chromosomes to segregate to the daughter cells, which in turn triggers premature exit from mitosis rather than a block at this phase of the cell cycle. ^[2] Docetaxel inhibits the clonogenic survival of Human cancer cell Hs746T (stomach), AGS (stomach), HeLa (cervix), CaSki (cervix), BxPC3 (pancreas), Capan-1 (pancreas) with IC50 of 1 nM, 1 nM, 0.3 nM, 0.3 nM, 0.3 nM and 0.3 nM respectively. ^[4] Docetaxel inhibits endothelial cell migration that does not affects microtubule gross morphology or inhibit cell proliferation, although they does produce more subtle effects on microtubule dynamics. Docetaxel inhibits HUVEC migration with an observed IC50 of 1 pM. HUVEC chemotaxis stimulated by either of two angiogenic factors, thymidine phosphorylase or VEGF, is inhibited by Docetaxel with IC 50 of 10 pM and is ablated at 1 nM. ^[7] Docetaxel induces human monocytes, but not RAW 264.7 murine macrophages, Prostaglandin H Synthase-2m (PGHS-2) expression. ^[8]

Cell Data

Cell Lines	Assay Type	Activity Description	PMID
HSC-3	Mni3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGTOZllKSzVyPUCuNFAxOTN{IN88US=>	NE\HZ3dUSU6JRWK=
5637	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MX;JR\|UxRTBwMECwNVQ{KM7:TR?=	NGLzeIZUSU6JRWK=
HT-144	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmDwTWM2OD1yLkCwNFE2PyEQvF2=	NYfDXXplW0GQR1XS
NCI-H292	M2rqRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHHEVVdKSzVyPUCuNFAxOTV7IN88US=>	NXjwTYNUW0GQR1XS
HCE-T	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFe5eYpKSzVyPUCuNFAxOTZ{IN88US=>	NHH5SlVUSU6JRWK=
ESS-1	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NY\lcG9uUUN3ME2wMlAxODF5OTFOwG0>	NU\5TnFuW0GQR1XS
D-566MG	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVfjN2cyUUN3ME2wMlAxODF6MjFOwG0>	NWewSVRzW0GQR1XS
CAL-62	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{iybmlEPTB;MD6wNFAyQDVizszN	NGCwc5pUSU6JRWK=
GT3TKB	M1jV[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXfteGt[UUN3ME2wMlAxODJ\|MjFOwG0>	NVfLXHVGW0GQR1XS
HSC-4	NWLqZmx{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYnqfoI1UUN3ME2wMlAxODJ\|OTFOwG0>	NYjXc25pW0GQR1XS
KOSC-2	MljSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmDBTWM2OD1yLkCwNFI2PSEQvF2=	M17uUHNCVkeHUh?=
NB14	NHLMfIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MXPJR\|UxRTBwMECwNlYh\|ryP	NVH6OGo4W0GQR1XS
ES8	MnPxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnHFTWM2OD1yLkCwNFI3KM7:TR?=	MW\TRW5ITVJ?
BFTC-905	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVnJR\|UxRTBwMECwNlY5KM7:TR?=	MkDTV2FPT0WU
A498	MkTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MYDJR\|UxRTBwMECwNlc5KM7:TR?=	MWfTRW5ITVJ?
HO-1-N-1	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NF;CVYtKSzVyPUCuNFAxOjhzIN88US=>	NX;qSmZ4W0GQR1XS
SF539	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NW\jbHpyUUN3ME2wMlAxODNyMjFOwG0>	M1j4NnNCVkeHUh?=
HuO-3N1	Mnz4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MW\JR\|UxRTBwMECwN\|AzKM7:TR?=	NXv5V4ViW0GQR1XS
NCI-H510A	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmjKTWM2OD1yLkCwNFM{PiEQvF2=	NUfJOlNtW0GQR1XS
CAL-27	MmDzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NIi4PI9KSzVyPUCuNFAxOzN7IN88US=>	NW\Q[XV3W0GQR1XS
TE-8	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NGjDb\|NKSzVyPUCuNFAxOzZ4IN88US=>	NELld3NUSU6JRWK=
VA-ES-BJ	M{TUO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MUXJR\|UxRTBwMECwN\|c2KM7:TR?=	MUjTRW5ITVJ?
RH-1	NVvhOnJ5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NHW3V2tKSzVyPUCuNFAxOzh4IN88US=>	MknBV2FPT0WU
COLO-800	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MnjETWM2OD1yLkCwNFM5QCEQvF2=	MWLTRW5ITVJ?
ES7	M3[5[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGLpblVKSzVyPUCuNFAxOzh7IN88US=>	MVHTRW5ITVJ?
GAMG	M4Kzcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NIewcI1KSzVyPUCuNFAxPDF4IN88US=>	MUHTRW5ITVJ?
Ca9-22	MnLDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYPJUnRwUUN3ME2wMlAxODR{MzFOwG0>	MXHTRW5ITVJ?
SBC-1	M3O4XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGPUUndKSzVyPUCuNFAxPDNizszN	M4nocHNCVkeHUh?=
RPMI-7951	NH\KWVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NEW1PVFKSzVyPUCuNFAxPDR6IN88US=>	M{fjXnNCVkeHUh?=
SW1710	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXvUTHZOUUN3ME2wMlAxODR4NjFOwG0>	MmLmV2FPT0WU
HGC-27	Mmn0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFfkfoFKSzVyPUCuNFAxPDdzIN88US=>	NFXPTm9USU6JRWK=
MC-IXC	MnvlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGWy[4pKSzVyPUCuNFAxPDd7IN88US=>	M{PDWHNCVkeHUh?=
FTC-133	NHvITXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MXXJR\|UxRTBwMECwOFg6KM7:TR?=	MWDTRW5ITVJ?
HT-1080	NUHNc2tTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2i2eGlEPTB;MD6wNFA2ODFizszN	NYDwW5pLW0GQR1XS
NMC-G1	Ml[3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFf0O2pKSzVyPUCuNFAxPTF5IN88US=>	MUXTRW5ITVJ?
GI-1	M2\zRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3\WeGlEPTB;MD6wNFA2OjhizszN	NHfoVHJUSU6JRWK=
CGTH-W-1	NUOxdY9vT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MUPJR\|UxRTBwMECwOVQzKM7:TR?=	Mmi2V2FPT0WU
A2058	NUHrRW5DT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXS2OZE5UUN3ME2wMlAxODV2NDFOwG0>	NIK3VlhUSU6JRWK=
ETK-1	MmnzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoTYTWM2OD1yLkCwNFU2QCEQvF2=	NULDXXVFW0GQR1XS
NEC8	M17Pcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Mki2TWM2OD1yLkCwNFU3OSEQvF2=	NXXHOZZjW0GQR1XS
TE-11	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NWnjSZhLUUN3ME2wMlAxODV4OTFOwG0>	MkjXV2FPT0WU
NCI-H720	MmLsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NV[z[pNsUUN3ME2wMlAxODV6IN88US=>	M4nkN3NCVkeHUh?=
PSN1	MoDES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2XlbmlEPTB;MD6wNFA2QDFizszN	NHjlPW1USU6JRWK=
SW780	MmO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M4jHbWlEPTB;MD6wNFA2QDdizszN	NIjR[5dUSU6JRWK=
8-MG-BA	NI\tUGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYD2VJRDUUN3ME2wMlAxODV6OTFOwG0>	NXriNVVlW0GQR1XS
EC-GI-10	MlvxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NUjZTG9bUUN3ME2wMlAxODV7MjFOwG0>	MYrTRW5ITVJ?
SJSA-1	NFfTd5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Ml7LTWM2OD1yLkCwNFYyPSEQvF2=	NYfiZXpJW0GQR1XS
639-V	NGT4b4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MluyTWM2OD1yLkCwNFY1PyEQvF2=	NHfrVnNUSU6JRWK=
PFSK-1	NGmxS\|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M1y0UGlEPTB;MD6wNFA3PTdizszN	NVi5fWkxW0GQR1XS
DMS-273	NGTVOItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVXJR\|UxRTBwMECwOlc1KM7:TR?=	M{PifnNCVkeHUh?=
TE-9	MkOyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2\ZbGlEPTB;MD6wNFA3PzZizszN	NHz4Z5pUSU6JRWK=
SCC-25	M3rnZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NYfh[FVmUUN3ME2wMlAxODZ6IN88US=>	M1XBcXNCVkeHUh?=
PA-1	NGraRXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXzNc\|F1UUN3ME2wMlAxODZ6NzFOwG0>	NFrZRXFUSU6JRWK=
MHH-ES-1	NIOzTotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{K0RWlEPTB;MD6wNFA4KM7:TR?=	MX;TRW5ITVJ?
Daoy	NGHZd3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NIPNXIJKSzVyPUCuNFAxPyEQvF2=	NWW0RWZ4W0GQR1XS
G-402	MoHaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MVnJR\|UxRTBwMECwO\|A3KM7:TR?=	MoXZV2FPT0WU
YKG-1	MkT5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3XKd2lEPTB;MD6wNFA4ODdizszN	M{e0TnNCVkeHUh?=
Ca-Ski	NFjmfVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVXJR\|UxRTBwMECwO\|I5KM7:TR?=	M3SyZnNCVkeHUh?=
CHP-212	NH:4N4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVzJR\|UxRTBwMECwO\|Mh\|ryP	M2P1Z3NCVkeHUh?=
SCC-4	NHf0RnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MlL1TWM2OD1yLkCwNFc{QSEQvF2=	M3XaWnNCVkeHUh?=
EW-3	M136WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{TiOmlEPTB;MD6wNFA4PDVizszN	M2jCTXNCVkeHUh?=
P12-ICHIKAWA	MkfRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlzoTWM2OD1yLkCwNFc1PSEQvF2=	M2q0ZnNCVkeHUh?=
HSC-2	NUPpdWhTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NV;yfWJrUUN3ME2wMlAxODd3NTFOwG0>	NHrDfnpUSU6JRWK=
HN	NYjZboVUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3zqemlEPTB;MD6wNFA4PThizszN	M{K4TnNCVkeHUh?=
LXF-289	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXHtTpdOUUN3ME2wMlAxODd3ODFOwG0>	NXrqSmwxW0GQR1XS
ES1	M1\LRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXjJR\|UxRTBwMECwO\|ch\|ryP	M{XOW3NCVkeHUh?=
NTERA-S-cl-D1	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2riW2lEPTB;MD6wNFA4PzNizszN	MYDTRW5ITVJ?
K5	NYP0RWZ[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MY\JR\|UxRTBwMECwO\|c5KM7:TR?=	MXHTRW5ITVJ?
HOS	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1rwd2lEPTB;MD6wNFA4QDJizszN	M4KzTHNCVkeHUh?=
YH-13	NX;STlJkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mm\yTWM2OD1yLkCwNFc6OSEQvF2=	MXnTRW5ITVJ?
SW954	NEPmNGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MmPLTWM2OD1yLkCwNFgzOyEQvF2=	MnG3V2FPT0WU
KYSE-510	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NV31TXQxUUN3ME2wMlAxODh2IN88US=>	MYjTRW5ITVJ?
8505C	NIj3SVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MV7JR\|UxRTBwMECwPFU1KM7:TR?=	MnHKV2FPT0WU
A549	MkTyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MV7JR\|UxRTBwMECwPFgzKM7:TR?=	NEnuUYRUSU6JRWK=
Detroit562	Mmj4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Ml;yTWM2OD1yLkCwNFkxOiEQvF2=	M2\yZnNCVkeHUh?=
ES5	NHvQVlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVzJR\|UxRTBwMECwPVEh\|ryP	MW\TRW5ITVJ?
KYSE-140	MmDiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmftTWM2OD1yLkCwNFk{OyEQvF2=	NF;JZWlUSU6JRWK=
GMS-10	M4e4W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGrub2VKSzVyPUCuNFAxQTRzIN88US=>	M2\JbnNCVkeHUh?=
D-263MG	NWW1T\|NWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXPzZphjUUN3ME2wMlAxODl2NzFOwG0>	MmDtV2FPT0WU
BCPAP	MoTmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MWfJR\|UxRTBwMECwPVQ4KM7:TR?=	NXfRbZU{W0GQR1XS
CHL-1	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NYPLV5FlUUN3ME2wMlAxODl3ODFOwG0>	NF;IWotUSU6JRWK=
RKO	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MkDzTWM2OD1yLkCwNFk5QSEQvF2=	M1jRZXNCVkeHUh?=
SW48	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmTpTWM2OD1yLkCwNVAyKM7:TR?=	NYW3eoM6W0GQR1XS
BPH-1	M1rweGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHnwVWdKSzVyPUCuNFAyODJizszN	MYfTRW5ITVJ?
EFO-27	NVjR[pdqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIjwV2VKSzVyPUCuNFAyODJizszN	NXu3O2VQW0GQR1XS
CAL-33	Mo\IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NITHfYpKSzVyPUCuNFAyODRizszN	M3XOPXNCVkeHUh?=
NCI-H1792	MnjRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{P3PGlEPTB;MD6wNFExPCEQvF2=	M3Gye3NCVkeHUh?=
BB30-HNC	MoDkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NWrzT5RKUUN3ME2wMlAxOTB3IN88US=>	MXPTRW5ITVJ?
VM-CUB-1	M3rEN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{jJc2lEPTB;MD6wNFExPSEQvF2=	NWCw[otGW0GQR1XS
TE-5	NHG0bVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3;tXWlEPTB;MD6wNFExPiEQvF2=	NU\1SmRJW0GQR1XS
NB13	MnPnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NETOWHBKSzVyPUCuNFAyODdizszN	MYHTRW5ITVJ?
NBsusSR	NHjqWpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MX7JR\|UxRTBwMECxNUDPxE1?	MkLYV2FPT0WU
LNCaP-Clone-FGC	NHnacHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVfJR\|UxRTBwMECxNUDPxE1?	NX3tNJJZW0GQR1XS
EPLC-272H	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NH36TplKSzVyPUCuNFAyOTFizszN	NFOzOVZUSU6JRWK=
KNS-62	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M4WxdGlEPTB;MD6wNFEyOiEQvF2=	NVzKUIxEW0GQR1XS
RERF-LC-MS	M3P4VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnnPTWM2OD1yLkCwNVE{KM7:TR?=	NH7jUYVUSU6JRWK=
LOXIMVI	NY\MXWxrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWH0dIVVUUN3ME2wMlAxOTF4IN88US=>	MojZV2FPT0WU
KINGS-1	Mn[zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3LaXmlEPTB;MD6wNFEyPyEQvF2=	NVrtTnNQW0GQR1XS
T98G	NYrOfm5ET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MX7JR\|UxRTBwMECxNVch\|ryP	NFzXWYNUSU6JRWK=
HCC1806	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NGDCTG1KSzVyPUCuNFAyOThizszN	MUfTRW5ITVJ?
MZ1-PC	NEDYeYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnXDTWM2OD1yLkCwNVE5KM7:TR?=	NHLmbYtUSU6JRWK=
RT-112	NWXlRWtOT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXT0bWZ5UUN3ME2wMlAxOTF7IN88US=>	MULTRW5ITVJ?
LK-2	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1W1R2lEPTB;MD6wNFEzOSEQvF2=	MlHBV2FPT0WU
A375	NY[2Vlg6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXTsNnZIUUN3ME2wMlAxOTJzIN88US=>	M4TIV3NCVkeHUh?=
SF268	NUO1W\|N3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MkjoTWM2OD1yLkCwNVIyKM7:TR?=	NIX4eHpUSU6JRWK=
H9	Mlr6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MVPJR\|UxRTBwMECxNlQh\|ryP	Ml:4V2FPT0WU
KYSE-410	NF7pT2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NV3UV4VnUUN3ME2wMlAxOTJ2IN88US=>	MUXTRW5ITVJ?
G-401	M{fSZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHzVd45KSzVyPUCuNFAyOjdizszN	MVTTRW5ITVJ?
SW982	M{nFfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXzpWlg2UUN3ME2wMlAxOTJ5IN88US=>	MW\TRW5ITVJ?
D-423MG	M3TBN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{\WZ2lEPTB;MD6wNFE{KM7:TR?=	MYrTRW5ITVJ?
CAMA-1	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYjJR\|UxRTBwMECxN\|Eh\|ryP	MoL5V2FPT0WU
SCC-9	M4\KVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MofJTWM2OD1yLkCwNVMzKM7:TR?=	NH3rNFRUSU6JRWK=
SAS	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NE[4eYRKSzVyPUCuNFAyOzRizszN	NYTpXJR[W0GQR1XS
KYSE-180	NXjSe455T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MnXsTWM2OD1yLkCwNVM2KM7:TR?=	NHnP[41USU6JRWK=
EW-16	M4H3Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NWfQfZc1UUN3ME2wMlAxOTN3IN88US=>	NV3EXHUxW0GQR1XS
HD-MY-Z	NG\nT5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnXSTWM2OD1yLkCwNVQyKM7:TR?=	M3;oRnNCVkeHUh?=
KYSE-450	M3HRbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M2q2OWlEPTB;MD6wNFE1OyEQvF2=	MYXTRW5ITVJ?
LCLC-97TM1	NWnWT3c1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWjJR\|UxRTBwMECxOFQh\|ryP	M3[0UnNCVkeHUh?=
KS-1	NYTkOm9GT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYDJR\|UxRTBwMECxOFQh\|ryP	M3rGbnNCVkeHUh?=
TI-73	MlHtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MVrJR\|UxRTBwMECxOFQh\|ryP	MUTTRW5ITVJ?
A427	M3KwbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Ml;pTWM2OD1yLkCwNVQ5KM7:TR?=	MVjTRW5ITVJ?
LB831-BLC	M3fROGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NY\4WHJIUUN3ME2wMlAxOTR6IN88US=>	M{\jVnNCVkeHUh?=
MG-63	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXzJR\|UxRTBwMECxOVEh\|ryP	MlPYV2FPT0WU
PANC-03-27	NELhUnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnnPTWM2OD1yLkCwNVU1KM7:TR?=	MoXEV2FPT0WU
23132-87	NHPRWFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVOzZ3VvUUN3ME2wMlAxOTV3IN88US=>	NVT5XnZnW0GQR1XS
ES4	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NGr3e\|NKSzVyPUCuNFAyPTVizszN	NGLvW5BUSU6JRWK=
KP-4	NUn3b2xDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3S0SWlEPTB;MD6wNFE2PiEQvF2=	Mn3uV2FPT0WU
NCI-H1703	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MonQTWM2OD1yLkCwNVU4KM7:TR?=	NGfQVG5USU6JRWK=
MCF7	MkfTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoizTWM2OD1yLkCwNVYyKM7:TR?=	NXSyPJpWW0GQR1XS
A172	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MlvETWM2OD1yLkCwNVY{KM7:TR?=	NVPTepRLW0GQR1XS
CAL-39	NX;wS4lxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Moi1TWM2OD1yLkCwNVY{KM7:TR?=	M3;afXNCVkeHUh?=
Saos-2	MoHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NIi2folKSzVyPUCuNFAyPjhizszN	NX3rTFVuW0GQR1XS
EW-11	NH;ue25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnH6TWM2OD1yLkCwNVY6KM7:TR?=	NXzXUWNKW0GQR1XS
D-336MG	NF3G[oVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYruNXNYUUN3ME2wMlAxOTZ7IN88US=>	M1LGU3NCVkeHUh?=
SW13	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MlHaTWM2OD1yLkCwNVY6KM7:TR?=	NV7mdngzW0GQR1XS
ME-180	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NX31NIR[UUN3ME2wMlAxOTZ7IN88US=>	NEPvTJNUSU6JRWK=
SK-MEL-2	MoLWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFy0bG9KSzVyPUCuNFAyPyEQvF2=	MlK3V2FPT0WU
697	M3\VcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3PUZmlEPTB;MD6wNFE4OiEQvF2=	M1S1ZXNCVkeHUh?=
D-247MG	Mn;KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MkjXTWM2OD1yLkCwNVc{KM7:TR?=	Mn\nV2FPT0WU
EoL-1-cell	NUX3c3R6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M4DJdmlEPTB;MD6wNFE4OyEQvF2=	MYDTRW5ITVJ?
MV-4-11	MlriS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Mn:2TWM2OD1yLkCwNVc1KM7:TR?=	M4fYW3NCVkeHUh?=
U-2-OS	NVrwOYdmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIe0fHhKSzVyPUCuNFAyPzVizszN	MlHsV2FPT0WU
NCI-H526	M{DWbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVnJR\|UxRTBwMECxO\|Yh\|ryP	M1qydXNCVkeHUh?=
SK-NEP-1	Mnu1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVKzXYNDUUN3ME2wMlAxOTd4IN88US=>	M3:wb3NCVkeHUh?=
DB	NH7Mc2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NFrRU5BKSzVyPUCuNFAyPzhizszN	M13DWXNCVkeHUh?=
GCT	NHzUTItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NGDQN4tKSzVyPUCuNFAyQCEQvF2=	MnrTV2FPT0WU
HCT-116	NFXGUmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2WxOWlEPTB;MD6wNFE5OSEQvF2=	M4POTXNCVkeHUh?=
AU565	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVfJR\|UxRTBwMECxPFEh\|ryP	M4Lz[3NCVkeHUh?=
KALS-1	M{LqN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFviZZJKSzVyPUCuNFAyQDFizszN	MWHTRW5ITVJ?
C2BBe1	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1LmdmlEPTB;MD6wNFE5OiEQvF2=	NFzoUXBUSU6JRWK=
Becker	MnPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVHqTphzUUN3ME2wMlAxOTh\|IN88US=>	MmPPV2FPT0WU
647-V	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFvJTGtKSzVyPUCuNFAyQDRizszN	NITkOmZUSU6JRWK=
NCI-H2122	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXjJR\|UxRTBwMECxPFQh\|ryP	MlP0V2FPT0WU
SBC-5	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MV3JR\|UxRTBwMECxPFch\|ryP	NYPsTHJpW0GQR1XS
NB17	M4TPVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MV\JR\|UxRTBwMECxPFkh\|ryP	NG\JVYtUSU6JRWK=
MHH-PREB-1	NV;ZTmtWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NFixcYpKSzVyPUCuNFAyQDlizszN	Moi0V2FPT0WU
M14	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmHBTWM2OD1yLkCwNVkyKM7:TR?=	NYm2e4dMW0GQR1XS
NCI-H1048	NIfmO5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXviXG1uUUN3ME2wMlAxOTl{IN88US=>	MXjTRW5ITVJ?
CTB-1	NVvWOIE3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWPJR\|UxRTBwMECxPVIh\|ryP	NUm4TmFqW0GQR1XS
SK-PN-DW	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NYDqZ5BvUUN3ME2wMlAxOTl2IN88US=>	NV7zdFRXW0GQR1XS
H4	M3KxdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NWLPT5dzUUN3ME2wMlAxOTl4IN88US=>	MX\TRW5ITVJ?
NCI-SNU-1	Mny2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHPOOVdKSzVyPUCuNFAyQTdizszN	MWrTRW5ITVJ?
M059J	MlLzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NETXU4lKSzVyPUCuNFAyQThizszN	MljmV2FPT0WU
OVCAR-5	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M4i0TWlEPTB;MD6wNFE6QSEQvF2=	MoLSV2FPT0WU
SK-MEL-28	Mnn6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MYjJR\|UxRTBwMECyNFMh\|ryP	NFfKUoZUSU6JRWK=
PC-14	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{TNcmlEPTB;MD6wNFIxQSEQvF2=	NWnrRWNSW0GQR1XS
OVCAR-8	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHjHem5KSzVyPUCuNFAzOTJizszN	MmDmV2FPT0WU
BB49-HNC	MoTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXuzd2NNUUN3ME2wMlAxOjF{IN88US=>	M1T1dnNCVkeHUh?=
EFM-19	M3:3Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYXJR\|UxRTBwMECyNVUh\|ryP	NFXqXJZUSU6JRWK=
BHY	NFfwW\|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NGLpbZJKSzVyPUCuNFAzOTZizszN	NFXKN29USU6JRWK=
SW756	MnHZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlzCTWM2OD1yLkCwNlE3KM7:TR?=	NEjJcFNUSU6JRWK=
TE-1	Mn7CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NY\TeplUUUN3ME2wMlAxOjF4IN88US=>	Mk\EV2FPT0WU
NCI-H2452	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MWTJR\|UxRTBwMECyNVYh\|ryP	MYHTRW5ITVJ?
NCI-H1581	MlXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmqzTWM2OD1yLkCwNlE4KM7:TR?=	NIe2Z4lUSU6JRWK=
COR-L23	Mm\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnTkTWM2OD1yLkCwNlIh\|ryP	M1LCXHNCVkeHUh?=
RXF393	MnPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NV;HXIx7UUN3ME2wMlAxOjJ{IN88US=>	NVuyXJZHW0GQR1XS
BFTC-909	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MnT5TWM2OD1yLkCwNlI2KM7:TR?=	NH3pT4hUSU6JRWK=
IST-MEL1	NWG2SJNwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MXrJR\|UxRTBwMECyNlUh\|ryP	MUTTRW5ITVJ?
NCI-H650	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2Lm[WlEPTB;MD6wNFIzPSEQvF2=	MUnTRW5ITVJ?
SK-UT-1	NGXibnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYnlfVAyUUN3ME2wMlAxOjJ4IN88US=>	Mm\rV2FPT0WU
GOTO	NHrkdJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MW\JR\|UxRTBwMECyNlch\|ryP	MYTTRW5ITVJ?
TYK-nu	NWnXdJYzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWW2UnNTUUN3ME2wMlAxOjN{IN88US=>	M1WzSXNCVkeHUh?=
JVM-3	NXfDUVFiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M{PzemlEPTB;MD6wNFI{OyEQvF2=	MVLTRW5ITVJ?
SK-MES-1	MljZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVjsSIN5UUN3ME2wMlAxOjN\|IN88US=>	NFj5cJhUSU6JRWK=
SK-HEP-1	MkXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Mn[xTWM2OD1yLkCwNlM1KM7:TR?=	MYLTRW5ITVJ?
J-RT3-T3-5	MmnYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHP4dYVKSzVyPUCuNFAzOzVizszN	NFL6TmpUSU6JRWK=
A673	NWnicGJPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MljWTWM2OD1yLkCwNlM2KM7:TR?=	NITZVopUSU6JRWK=
NCI-H446	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MoHsTWM2OD1yLkCwNlQ{KM7:TR?=	MUDTRW5ITVJ?
RPMI-2650	Ml;nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlLDTWM2OD1yLkCwNlQ3KM7:TR?=	M{XSXXNCVkeHUh?=
HCE-4	M3fHPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnPtTWM2OD1yLkCwNlQ4KM7:TR?=	MWnTRW5ITVJ?
KGN	M{Xnd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MoX2TWM2OD1yLkCwNlQ4KM7:TR?=	M37LNnNCVkeHUh?=
U251	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVXJR\|UxRTBwMECyOUDPxE1?	Ml;JV2FPT0WU
BxPC-3	M2rIdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MmfKTWM2OD1yLkCwNlUyKM7:TR?=	MWfTRW5ITVJ?
VMRC-RCZ	MmrqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHTRXmdKSzVyPUCuNFAzPTJizszN	M3nPO3NCVkeHUh?=
TE-10	NHvoWHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NGTPW4VKSzVyPUCuNFAzPTRizszN	M2PJcXNCVkeHUh?=
OC-314	NUDHenlPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYfJR\|UxRTBwMECyOVYh\|ryP	NF7O[GVUSU6JRWK=
NCI-H1437	MkLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NH\zfm1KSzVyPUCuNFAzPiEQvF2=	M{[w[nNCVkeHUh?=
SNU-387	Ml7yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MkW4TWM2OD1yLkCwNlYyKM7:TR?=	MYrTRW5ITVJ?
A388	Mlq3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXPB[JR[UUN3ME2wMlAxOjZ3IN88US=>	NFywOlFUSU6JRWK=
C-33-A	M1m3dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M33memlEPTB;MD6wNFI3PiEQvF2=	NVvlZpdtW0GQR1XS
CAL-51	M2XL[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NYrQVWJ6UUN3ME2wMlAxOjdzIN88US=>	M1vYRnNCVkeHUh?=
Hs-578-T	M2W0Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnjWTWM2OD1yLkCwNlczKM7:TR?=	MW\TRW5ITVJ?
MDA-MB-415	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NULWem1UUUN3ME2wMlAxOjd2IN88US=>	NYnUWox7W0GQR1XS
SW1417	NEHhfolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{f2dGlEPTB;MD6wNFI4PiEQvF2=	NETX[nNUSU6JRWK=
HCC70	Mk[4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MWDJR\|UxRTBwMECyO\|ch\|ryP	MlfXV2FPT0WU
ES3	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVHmT3dXUUN3ME2wMlAxOjd5IN88US=>	MVLTRW5ITVJ?
KYSE-270	NX7aVWtxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mmm4TWM2OD1yLkCwNlc5KM7:TR?=	M{DwZ3NCVkeHUh?=
HT-29	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVW2O4l{UUN3ME2wMlAxOjhizszN	M4HGWXNCVkeHUh?=
MDA-MB-361	NYfQXmM1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MVfJR\|UxRTBwMECyPFEh\|ryP	NVS5Z3ppW0GQR1XS
RPMI-8866	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NEL6bXlKSzVyPUCuNFAzQDFizszN	NIXlU2pUSU6JRWK=
JEG-3	NYH1N5M1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NGG0bXpKSzVyPUCuNFAzQDJizszN	MWnTRW5ITVJ?
HT-3	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVvrZ\|RRUUN3ME2wMlAxOjh{IN88US=>	Ml75V2FPT0WU
HTC-C3	Mo\BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NIrNdZVKSzVyPUCuNFAzQDVizszN	MknzV2FPT0WU
NCI-H209	MmHWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NV3FXoVCUUN3ME2wMlAxOjh4IN88US=>	NUPLXIp2W0GQR1XS
SKG-IIIa	MkHLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXfCcJNXUUN3ME2wMlAxOjh4IN88US=>	MWnTRW5ITVJ?
SW962	NUfM[ndnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mk\oTWM2OD1yLkCwNlk{KM7:TR?=	MnziV2FPT0WU
LCLC-103H	Mn2yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NF3TeJVKSzVyPUCuNFAzQTNizszN	NULCSlVMW0GQR1XS
DOK	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3vSfGlEPTB;MD6wNFI6PCEQvF2=	MkKyV2FPT0WU
SW1088	MkD1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2TxR2lEPTB;MD6wNFI6PSEQvF2=	MYLTRW5ITVJ?
GP5d	NIjVW5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NEHwSVZKSzVyPUCuNFAzQTZizszN	M{P1SnNCVkeHUh?=
EW-1	M1vze2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3X0SmlEPTB;MD6wNFI6QCEQvF2=	NV\1TZhJW0GQR1XS
CP66-MEL	NF7sPYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MUjJR\|UxRTBwMECzJO69VQ>?	MUnTRW5ITVJ?
DEL	NF3yToFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NETRWG1KSzVyPUCuNFA{ODFizszN	M3\PWnNCVkeHUh?=
DU-4475	M1[wfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXLGco1KUUN3ME2wMlAxOzB{IN88US=>	NGDJNFJUSU6JRWK=
HEC-1	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NIW2NXFKSzVyPUCuNFA{ODNizszN	NEfLVoRUSU6JRWK=
U031	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MWTJR\|UxRTBwMECzNFch\|ryP	MlzaV2FPT0WU
BB65-RCC	M37VcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnXhTWM2OD1yLkCwN\|A5KM7:TR?=	MYHTRW5ITVJ?
NUGC-3	NVvufYZNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYjJR\|UxRTBwMECzNFgh\|ryP	M2LWXnNCVkeHUh?=
IST-SL1	MmrwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MWPJR\|UxRTBwMECzNVIh\|ryP	MmL1V2FPT0WU
LS-411N	Mm\4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MYDJR\|UxRTBwMECzNVQh\|ryP	NYLKTXY5W0GQR1XS
22RV1	M3Pve2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MmPUTWM2OD1yLkCwN\|E2KM7:TR?=	NIXs[FNUSU6JRWK=
MKN28	NI\zXHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M4jWeWlEPTB;MD6wNFMyPyEQvF2=	NX\KOXV5W0GQR1XS
ONS-76	M4LK[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXT2NndGUUN3ME2wMlAxOzJ{IN88US=>	NVn5U2JNW0GQR1XS
SH-4	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MUDJR\|UxRTBwMECzNlIh\|ryP	NYrlWG8yW0GQR1XS
MIA-PaCa-2	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYfJR\|UxRTBwMECzNlQh\|ryP	NU\EVnUzW0GQR1XS
CaR-1	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NEHNbnpKSzVyPUCuNFA{OjdizszN	NXfYVVY4W0GQR1XS
AGS	M2DyXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGTJTWtKSzVyPUCuNFA{OjhizszN	NVP5W5d4W0GQR1XS
SF126	Ml7tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Ml3STWM2OD1yLkCwN\|I6KM7:TR?=	MVfTRW5ITVJ?
UACC-62	M1e4[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFjHelVKSzVyPUCuNFA{OyEQvF2=	MojyV2FPT0WU
NCI-H28	NUXGVVRGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWnWdYNkUUN3ME2wMlAxOzN2IN88US=>	MVnTRW5ITVJ?
A2780	NEnMfWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MYrJR\|UxRTBwMECzN\|Uh\|ryP	Mn7iV2FPT0WU
CTV-1	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MUjJR\|UxRTBwMECzN\|ch\|ryP	MVjTRW5ITVJ?
LC-2-ad	NIPtNFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NGnVcpNKSzVyPUCuNFA{PCEQvF2=	NYTXZWZ2W0GQR1XS
NCI-H1770	M1j0Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NUSxS49yUUN3ME2wMlAxOzR{IN88US=>	NIHzTVlUSU6JRWK=
HuO9	M4fhOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFLmNpNKSzVyPUCuNFA{PDZizszN	M{PlPHNCVkeHUh?=
U-266	NVrmS2JIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NEjRPZdKSzVyPUCuNFA{PDhizszN	MXfTRW5ITVJ?
MLMA	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHXZNnBKSzVyPUCuNFA{PTVizszN	NU\MPGZ{W0GQR1XS
U-87-MG	NF3JW3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MYnJR\|UxRTBwMECzOVUh\|ryP	MXjTRW5ITVJ?
GI-ME-N	NFi2OG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MYHJR\|UxRTBwMECzOVgh\|ryP	MonCV2FPT0WU
HL-60	NY[yR5k4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MU\JR\|UxRTBwMECzOVkh\|ryP	NGrWeWZUSU6JRWK=
EGI-1	NX3tZ2VET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MmrvTWM2OD1yLkCwN\|YzKM7:TR?=	Mk\1V2FPT0WU
NCI-H23	NH6xZ4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUDzO4dpUUN3ME2wMlAxOzZ2IN88US=>	M3LTNXNCVkeHUh?=
NCI-H226	M1fES2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3XpUGlEPTB;MD6wNFM3QCEQvF2=	MmDHV2FPT0WU
NCI-H520	MnexS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnOwTWM2OD1yLkCwN\|czKM7:TR?=	M33VNHNCVkeHUh?=
L-363	M1;GcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NV3PeG5VUUN3ME2wMlAxOzd4IN88US=>	Mon2V2FPT0WU
CAL-12T	NFq0RZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NFfWfFNKSzVyPUCuNFA{PzZizszN	M1rvZ3NCVkeHUh?=
BT-20	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NUPBOJpLUUN3ME2wMlAxOzd4IN88US=>	NWXkNoVpW0GQR1XS
SNB75	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NUTpTHdzUUN3ME2wMlAxOzhzIN88US=>	NUL5ZlJZW0GQR1XS
A4-Fuk	NVjBcnZZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mm\qTWM2OD1yLkCwN\|kh\|ryP	NEi4O4NUSU6JRWK=
BE-13	M2DDVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MUjJR\|UxRTBwMECzPVMh\|ryP	M1u3SnNCVkeHUh?=
NCI-H1395	NIOzVVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NFTxXVlKSzVyPUCuNFA{QTZizszN	M2P5fnNCVkeHUh?=
SW620	MmHNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{Xuc2lEPTB;MD6wNFM6PyEQvF2=	MmfyV2FPT0WU
KNS-81-FD	MoHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmjaTWM2OD1yLkCwN\|k6KM7:TR?=	NUn1VmxZW0GQR1XS
RD	NEfaWHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{GwcWlEPTB;MD6wNFQh\|ryP	M2LlTXNCVkeHUh?=
HLE	NWjtNpQ2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NHO4UGlKSzVyPUCuNFA1ODVizszN	M1rhXHNCVkeHUh?=
OVCAR-3	NVHGN2J[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NGTDZ5ZKSzVyPUCuNFA1ODdizszN	MVHTRW5ITVJ?
KM12	NF7odGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M4r4PGlEPTB;MD6wNFQxQCEQvF2=	M2m0S3NCVkeHUh?=
HCC2998	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3PBTmlEPTB;MD6wNFQxQCEQvF2=	MXPTRW5ITVJ?
D-502MG	MnjhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHLpXWJKSzVyPUCuNFA1OSEQvF2=	MUTTRW5ITVJ?
KNS-42	MmXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M4fFWGlEPTB;MD6wNFQyOiEQvF2=	M13oTHNCVkeHUh?=
LS-123	M3vUTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXyxPHBvUUN3ME2wMlAxPDJ3IN88US=>	MmDQV2FPT0WU
SiHa	Mke4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{joNmlEPTB;MD6wNFQ{KM7:TR?=	MkPEV2FPT0WU
T47D	Mmr4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{DkPWlEPTB;MD6wNFQ{OSEQvF2=	NVHabnBzW0GQR1XS
EW-24	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXf4V4h3UUN3ME2wMlAxPDN\|IN88US=>	MoHLV2FPT0WU
CAL-120	NX\P[o0zT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NHn2cohKSzVyPUCuNFA1OzVizszN	M3nLZ3NCVkeHUh?=
JAR	NUT0bmJJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MUTJR\|UxRTBwMEC0N\|ch\|ryP	M4rTVHNCVkeHUh?=
QIMR-WIL	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmHxTWM2OD1yLkCwOFM5KM7:TR?=	NGjaVYNUSU6JRWK=
OCUB-M	M4S5UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M2HXemlEPTB;MD6wNFQ{QCEQvF2=	M1ztfnNCVkeHUh?=
Calu-6	M2ftZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MUHJR\|UxRTBwMEC0OFch\|ryP	NIjySYNUSU6JRWK=
MDA-MB-453	NWfBW3ZyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mn7DTWM2OD1yLkCwOFUyKM7:TR?=	NV;V[GNZW0GQR1XS
MKN45	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmXNTWM2OD1yLkCwOFU{KM7:TR?=	Mn64V2FPT0WU
ECC10	M2i4cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWLJR\|UxRTBwMEC0OkDPxE1?	NYTQWnRTW0GQR1XS
RVH-421	NVTENFBDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MoDwTWM2OD1yLkCwOFYyKM7:TR?=	NYTud4liW0GQR1XS
TGBC11TKB	M1m2N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFrnXmdKSzVyPUCuNFA1PjlizszN	MnnQV2FPT0WU
MOLT-4	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NW\JVnBUUUN3ME2wMlAxPDdzIN88US=>	NIjrfpZUSU6JRWK=
LN-405	MlL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmfFTWM2OD1yLkCwOFgzKM7:TR?=	NVvpSnZzW0GQR1XS
S-117	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NYDxbIZoUUN3ME2wMlAxPDh4IN88US=>	MmHwV2FPT0WU
RPMI-8226	Ml\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NWjRVFJQUUN3ME2wMlAxPDl5IN88US=>	MUfTRW5ITVJ?
KYSE-150	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXr5PHQ4UUN3ME2wMlAxPDl7IN88US=>	NWTmVWl[W0GQR1XS
NCI-H1666	MorMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFX3RllKSzVyPUCuNFA2ODVizszN	MnzlV2FPT0WU
Mewo	NFjaR2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVnLbWlUUUN3ME2wMlAxPTB3IN88US=>	MWLTRW5ITVJ?
AN3-CA	M4OxVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnLhTWM2OD1yLkCwOVA4KM7:TR?=	M2\CT3NCVkeHUh?=
COLO-680N	NIXKTFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mkf0TWM2OD1yLkCwOVA5KM7:TR?=	MkK4V2FPT0WU
FADU	NE\ZfGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2LpUGlEPTB;MD6wNFUyKM7:TR?=	NXG0dIVNW0GQR1XS
GB-1	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2DVdWlEPTB;MD6wNFUyOSEQvF2=	NGPmTnVUSU6JRWK=
KASUMI-1	NELs[\|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NV7Pc4FkUUN3ME2wMlAxPTFzIN88US=>	Mn\RV2FPT0WU
NOMO-1	NWLpOItUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYfJR\|UxRTBwMEC1NVMh\|ryP	NHTjO3JUSU6JRWK=
BV-173	NXnlTYdNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3Hh[GlEPTB;MD6wNFU{KM7:TR?=	MYPTRW5ITVJ?
RO82-W-1	NIrNNWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{\3V2lEPTB;MD6wNFU{OSEQvF2=	NWf3UnFEW0GQR1XS
LB2241-RCC	NIXIWFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MknxTWM2OD1yLkCwOVMyKM7:TR?=	MVjTRW5ITVJ?
NCI-H2170	NGTHdmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MofVTWM2OD1yLkCwOVM2KM7:TR?=	MkHOV2FPT0WU
SK-N-AS	NYHGb41vT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYHM[INzUUN3ME2wMlAxPTN3IN88US=>	NVjKRWw4W0GQR1XS
NCI-H1651	MnTKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHW4T3RKSzVyPUCuNFA2PCEQvF2=	MnXBV2FPT0WU
NCI-SNU-5	M1vmfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYjJR\|UxRTBwMEC1OFUh\|ryP	MWHTRW5ITVJ?
SN12C	NHLk[oZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2PqUWlEPTB;MD6wNFU2KM7:TR?=	M{XmSnNCVkeHUh?=
KY821	M{W5c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NVjQb4k6UUN3ME2wMlAxPTVzIN88US=>	MV;TRW5ITVJ?
SW1573	MlnjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3nuSGlEPTB;MD6wNFU2PCEQvF2=	MkPNV2FPT0WU
OE19	MkWxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MYjJR\|UxRTBwMEC1OVkh\|ryP	MVfTRW5ITVJ?
MPP-89	NFXMe3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUXRSYtXUUN3ME2wMlAxPTZ5IN88US=>	Mn3MV2FPT0WU
HuCCT1	M{ntRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{Di[WlEPTB;MD6wNFU3QCEQvF2=	MUDTRW5ITVJ?
SW1783	M3qxVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1PMVGlEPTB;MD6wNFU4KM7:TR?=	MnmxV2FPT0WU
8305C	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVz4UlRkUUN3ME2wMlAxPTd4IN88US=>	NFHGfWhUSU6JRWK=
OVCAR-4	NV[wN3BzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NV6yZlBWUUN3ME2wMlAxPTh4IN88US=>	NVfjVIl[W0GQR1XS
MMAC-SF	M4HHUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnXETWM2OD1yLkCwOVg3KM7:TR?=	NGXvXppUSU6JRWK=
COLO-824	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Ml7NTWM2OD1yLkCwOVkh\|ryP	MkjUV2FPT0WU
HCC38	Ml7JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NE[3[4pKSzVyPUCuNFA3KM7:TR?=	MYrTRW5ITVJ?
NCI-H1648	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NEfhW3hKSzVyPUCuNFA3ODFizszN	NXfoSnp2W0GQR1XS
NCI-H1573	M4jMbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVnJR\|UxRTBwMEC2NFch\|ryP	NH2zZZZUSU6JRWK=
MFM-223	Ml:4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1\N[2lEPTB;MD6wNFYyPiEQvF2=	MVrTRW5ITVJ?
NCI-H810	NGj4V2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NEHXUW9KSzVyPUCuNFA3OjJizszN	M{L4WnNCVkeHUh?=
EM-2	NGfZeHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MoL6TWM2OD1yLkCwOlI{KM7:TR?=	NF25cJVUSU6JRWK=
D-283MED	NXTnOoJ5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3;nWWlEPTB;MD6wNFYzPCEQvF2=	MXzTRW5ITVJ?
NCI-H1755	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NX6wfI5nUUN3ME2wMlAxPjJ2IN88US=>	Ml35V2FPT0WU
KYSE-70	NHG2WnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NWjzXWxbUUN3ME2wMlAxPjJ2IN88US=>	MULTRW5ITVJ?
SW626	MlLSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFLDWmJKSzVyPUCuNFA3OjRizszN	NWPzT4g3W0GQR1XS
WM-115	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NF6zbIhKSzVyPUCuNFA3OjdizszN	MkfPV2FPT0WU
NB69	NW[yfoJnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWnJR\|UxRTBwMEC2Nlkh\|ryP	MoD0V2FPT0WU
DOHH-2	NX64c5J5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MWLJR\|UxRTBwMEC2N{DPxE1?	MmDtV2FPT0WU
MEL-JUSO	M2X2OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M{nYS2lEPTB;MD6wNFY{QSEQvF2=	NYGyc2o1W0GQR1XS
IGR-1	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MX\JR\|UxRTBwMEC2OFEh\|ryP	MX\TRW5ITVJ?
ACN	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVfJR\|UxRTBwMEC2OFQh\|ryP	NHPUUZBUSU6JRWK=
KARPAS-45	NIrRfFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVHJR\|UxRTBwMEC2OVIh\|ryP	MVPTRW5ITVJ?
HC-1	NEDhXVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVnJR\|UxRTBwMEC2OVYh\|ryP	NWLQNI1XW0GQR1XS
MZ2-MEL	NWD0VHl{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M4TJNmlEPTB;MD6wNFY2QCEQvF2=	NUC4UGxHW0GQR1XS
NCI-H1355	M4LrSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NYrZWIl1UUN3ME2wMlAxPjd7IN88US=>	MlzqV2FPT0WU
HuP-T4	NYDN[JhQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MoK0TWM2OD1yLkCwOlc6KM7:TR?=	MkD6V2FPT0WU
AsPC-1	NWXpPGVDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MUPJR\|UxRTBwMEC2PFMh\|ryP	NH;Ze\|VUSU6JRWK=
SCC-15	NY[5WXI2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYLJR\|UxRTBwMEC2PFkh\|ryP	M2ra[nNCVkeHUh?=
CP50-MEL-B	M2\ZOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NUm4b\|N[UUN3ME2wMlAxPjl\|IN88US=>	MUPTRW5ITVJ?
DMS-114	M3;sWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NEWzUGFKSzVyPUCuNFA3QTZizszN	NHL0WWVUSU6JRWK=
KYSE-520	Mni2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1vCO2lEPTB;MD6wNFch\|ryP	MmHnV2FPT0WU
NCI-H2228	NHnZ[VlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUO4OGs6UUN3ME2wMlAxPzJ3IN88US=>	NFq2T\|BUSU6JRWK=
COLO-829	M3TuZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXjJR\|UxRTBwMEC3NlUh\|ryP	NIPzOVFUSU6JRWK=
NCI-H2052	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFHMeY5KSzVyPUCuNFA4OjdizszN	M4rUeXNCVkeHUh?=
HOP-92	MlvFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Mo\iTWM2OD1yLkCwO\|Mh\|ryP	NWLpb2RkW0GQR1XS
MDA-MB-231	M3TuOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MmDNTWM2OD1yLkCwO\|Mh\|ryP	M1HDcHNCVkeHUh?=
SK-MEL-30	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MX3JR\|UxRTBwMEC3N\|Ih\|ryP	MlG1V2FPT0WU
NCI-H2087	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2XSZmlEPTB;MD6wNFc1QCEQvF2=	NV7GcHBEW0GQR1XS
SW900	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Mnu5TWM2OD1yLkCwO\|U2KM7:TR?=	MXzTRW5ITVJ?
NCI-H358	NGjOTZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NFG0ZY5KSzVyPUCuNFA4PThizszN	MVvTRW5ITVJ?
NCI-H2126	NIPyPFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MXHJR\|UxRTBwMEC3O\|Mh\|ryP	MnLjV2FPT0WU
TGBC24TKB	NYKwZlJLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NUXYZ4RlUUN3ME2wMlAxPzhzIN88US=>	NF7YSpZUSU6JRWK=
786-0	MkD5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NWT1S\|RrUUN3ME2wMlAxPzh4IN88US=>	NYnWe3RqW0GQR1XS
no-10	NVn0bngyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NUDweGRnUUN3ME2wMlAxPzh6IN88US=>	NXjoOFZCW0GQR1XS
SCH	M1\tcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MX\JR\|UxRTBwMEC4NVgh\|ryP	MYXTRW5ITVJ?
COLO-741	NUTkO2tNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NF;GUXFKSzVyPUCuNFA5OiEQvF2=	Mn6xV2FPT0WU
NCI-H82	M3fhSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXvadlJjUUN3ME2wMlAxQDJ{IN88US=>	NUHTfIVwW0GQR1XS
MOLT-16	MoH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NX3sTIVzUUN3ME2wMlAxQDJ5IN88US=>	M4\YUXNCVkeHUh?=
IST-MES1	NXLvVXprT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MofpTWM2OD1yLkCwPFQh\|ryP	M{L3SnNCVkeHUh?=
NCI-H1623	MlnyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmTPTWM2OD1yLkCwPFU3KM7:TR?=	MXPTRW5ITVJ?
NCI-H1299	MlXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NV\FPVd{UUN3ME2wMlAxQDV5IN88US=>	MlnzV2FPT0WU
SNU-423	NEX0VVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MmrWTWM2OD1yLkCwPFU4KM7:TR?=	MXLTRW5ITVJ?
ALL-PO	NF7KVJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MoWzTWM2OD1yLkCwPFYh\|ryP	NX33NJJFW0GQR1XS
DK-MG	NXnwZ2psT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MoLPTWM2OD1yLkCwPFYh\|ryP	MkPOV2FPT0WU
LB1047-RCC	M{TzUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVnJR\|UxRTBwMEC4PEDPxE1?	MmW1V2FPT0WU
OMC-1	NI\lSWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MXTJR\|UxRTBwMEC5NFYh\|ryP	NYHIS2JVW0GQR1XS
TGBC1TKB	M1vyZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NWfRZo9{UUN3ME2wMlAxQTFizszN	NV;COIlwW0GQR1XS
DBTRG-05MG	M1:1TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3fMO2lEPTB;MD6wNFkyPyEQvF2=	MmTGV2FPT0WU
HPAF-II	NXLnTFB{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MX3JR\|UxRTBwMEC5NlYh\|ryP	MVzTRW5ITVJ?
A204	MofyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NITlVpBKSzVyPUCuNFA6OzRizszN	MYHTRW5ITVJ?
TK10	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MorQTWM2OD1yLkCwPVc4KM7:TR?=	NG\VW25USU6JRWK=
BHT-101	NGDBN5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NH3hPYxKSzVyPUCuNFA6QCEQvF2=	MYXTRW5ITVJ?
SK-N-DZ	MlPnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmXPTWM2OD1yLkCwPVg{KM7:TR?=	MX\TRW5ITVJ?
ChaGo-K-1	NEfxZZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NG\WblVKSzVyPUCuNFA6QDhizszN	MXHTRW5ITVJ?
NCI-H661	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1zxWGlEPTB;MD6wNVAxPSEQvF2=	MmXzV2FPT0WU
AM-38	NGn4bpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MmnBTWM2OD1yLkCxNFI1KM7:TR?=	MmjyV2FPT0WU
ML-2	M3j4cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHHSV2NKSzVyPUCuNFExOjlizszN	M33Td3NCVkeHUh?=
TCCSUP	NH;JNldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2TpcmlEPTB;MD6wNVA{PiEQvF2=	MWLTRW5ITVJ?
SW1990	NFG2UGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2jxZWlEPTB;MD6wNVA1PyEQvF2=	NI\rR5dUSU6JRWK=
HCC1395	NXvYWFVmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MVPJR\|UxRTBwMEGwOVYh\|ryP	MUDTRW5ITVJ?
PANC-10-05	M1:1cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NIL0PXFKSzVyPUCuNFExPTZizszN	MXnTRW5ITVJ?
CAKI-1	NGqyXmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mn;HTWM2OD1yLkCxNFc{KM7:TR?=	NV\uNYZXW0GQR1XS
HuP-T3	NGnIdYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUi5OnpzUUN3ME2wMlAyODd5IN88US=>	MmrPV2FPT0WU
HT-1197	NWe4VIFHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MV\JR\|UxRTBwMEGwPFQh\|ryP	NGPLO\|VUSU6JRWK=
MOLT-13	M4HvVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MoPxTWM2OD1yLkCxNFg3KM7:TR?=	MmflV2FPT0WU
NCI-H1563	M{LNdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFvhfpVKSzVyPUCuNFExQDdizszN	NYTkNHVmW0GQR1XS
NCI-N87	NXrNZ5g{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1fXS2lEPTB;MD6wNVA6OyEQvF2=	MXXTRW5ITVJ?
LB373-MEL-D	M3T5NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NUjhXXJFUUN3ME2wMlAyODl2IN88US=>	NGPJUplUSU6JRWK=
EFO-21	MnTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{ntT2lEPTB;MD6wNVEh\|ryP	MnG3V2FPT0WU
LU-134-A	NYjBNWw3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MnXsTWM2OD1yLkCxNVAzKM7:TR?=	NVfpOVdWW0GQR1XS
DU-145	NVHIS5JqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NFH6[llKSzVyPUCuNFEyODdizszN	NW\ubYFSW0GQR1XS
SF295	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NVnUSnhMUUN3ME2wMlAyOTJ4IN88US=>	M1PtcnNCVkeHUh?=
ABC-1	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MUHJR\|UxRTBwMEGxOFYh\|ryP	NFq1fXhUSU6JRWK=
TE-6	NYPCcY5DT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NV63RYJYUUN3ME2wMlAyOTR6IN88US=>	MlW4V2FPT0WU
GAK	NIHKcJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NG\LSm9KSzVyPUCuNFEyPThizszN	MYfTRW5ITVJ?
LU-139	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NWT4WHRZUUN3ME2wMlAyOTZ4IN88US=>	M3ztPXNCVkeHUh?=
EW-18	NYnwU3NWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1i4TGlEPTB;MD6wNVE3QSEQvF2=	M13xd3NCVkeHUh?=
MSTO-211H	MkHFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVnTc5NEUUN3ME2wMlAyOTd\|IN88US=>	M3jFdnNCVkeHUh?=
KU812	NVfrZpNzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MXjJR\|UxRTBwMEGxPVgh\|ryP	NEPwWnNUSU6JRWK=
NCI-H441	NULzWYZFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MkjDTWM2OD1yLkCxNVk5KM7:TR?=	MlrGV2FPT0WU
LU-99A	NYe0ZVg2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MUHJR\|UxRTBwMEGyJO69VQ>?	M1Xob3NCVkeHUh?=
NB10	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NGXVfWJKSzVyPUCuNFEzODlizszN	MXvTRW5ITVJ?
NCI-H1650	MkDvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2jCTmlEPTB;MD6wNVIzQSEQvF2=	MX7TRW5ITVJ?
YAPC	MkXqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYHlSpNlUUN3ME2wMlAyOjN5IN88US=>	MX\TRW5ITVJ?
HT55	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MUfJR\|UxRTBwMEGyOFIh\|ryP	MXzTRW5ITVJ?
NB7	MlixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Mk\BTWM2OD1yLkCxNlQ{KM7:TR?=	NWnCUIk6W0GQR1XS
NCI-H2030	Ml3yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NUPnT3l[UUN3ME2wMlAyOjV2IN88US=>	MorSV2FPT0WU
EW-22	Mm\qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NULPW3FZUUN3ME2wMlAyOjV4IN88US=>	M{LwO3NCVkeHUh?=
UMC-11	NFLQRpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M1nOWWlEPTB;MD6wNVI5OyEQvF2=	MVXTRW5ITVJ?
MKN7	NXnVb\|VFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3PyRWlEPTB;MD6wNVI5OyEQvF2=	M4\LVnNCVkeHUh?=
OE33	NHy1XXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M135e2lEPTB;MD6wNVMh\|ryP	NYXIOXpsW0GQR1XS
SK-LU-1	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1fOfGlEPTB;MD6wNVMzPCEQvF2=	MlXWV2FPT0WU
LAMA-84	NYm3[lN1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2DMdmlEPTB;MD6wNVMzQCEQvF2=	NVrufoFxW0GQR1XS
IA-LM	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYDJR\|UxRTBwMEGzN{DPxE1?	MmPUV2FPT0WU
HuH-7	NWHkbIhST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NX7rblk6UUN3ME2wMlAyOzV2IN88US=>	MW\TRW5ITVJ?
J82	NY\URXhpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MXPJR\|UxRTBwMEGzPUDPxE1?	NGTqWHhUSU6JRWK=
CFPAC-1	M{\DXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NY\KXJhSUUN3ME2wMlAyPDB4IN88US=>	MWfTRW5ITVJ?
MN-60	MlP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3Hi[GlEPTB;MD6wNVQzQSEQvF2=	MY\TRW5ITVJ?
A704	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYfJR\|UxRTBwMEG0N\|gh\|ryP	MlTOV2FPT0WU
SW684	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MlrtTWM2OD1yLkCxOFUzKM7:TR?=	NYrDPJFPW0GQR1XS
NOS-1	MkXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Ml\zTWM2OD1yLkCxOFYh\|ryP	NGL3UXZUSU6JRWK=
U-118-MG	M1\MfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M2HVPGlEPTB;MD6wNVQ4KM7:TR?=	MWXTRW5ITVJ?
NCI-H596	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFvlTFBKSzVyPUCuNFE1PzdizszN	NF;RcGhUSU6JRWK=
RS4-11	NIjGeXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M1r3cmlEPTB;MD6wNVUyPiEQvF2=	MkXYV2FPT0WU
KP-N-YS	MlvES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NH\CVpNKSzVyPUCuNFE2OjNizszN	MkT5V2FPT0WU
MS-1	M4f1e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M3TRO2lEPTB;MD6wNVU1PSEQvF2=	NID4dFRUSU6JRWK=
A101D	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2DBOGlEPTB;MD6wNVU1QSEQvF2=	M13MRXNCVkeHUh?=
DSH1	NVLOOWVtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MkXVTWM2OD1yLkCxOkDPxE1?	MmDnV2FPT0WU
CAS-1	Mn\FS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmiyTWM2OD1yLkCxOlA6KM7:TR?=	NGfacG1USU6JRWK=
NCI-H2347	M1vBSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHHnZWxKSzVyPUCuNFE3OzZizszN	NV;4ToZqW0GQR1XS
T-24	NWjjWY52T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MlTCTWM2OD1yLkCxO\|A2KM7:TR?=	MXHTRW5ITVJ?
MEG-01	M2q0Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M4LQ[GlEPTB;MD6wNVc{PyEQvF2=	NGHUWYhUSU6JRWK=
NCI-H2291	MnnjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYTmfmVyUUN3ME2wMlAyQDN6IN88US=>	MYPTRW5ITVJ?
SW872	NX7D[HhMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NGXOblRKSzVyPUCuNFE5PjdizszN	NIS5WG1USU6JRWK=
no-11	Mm\mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NXvMeXRUUUN3ME2wMlAyQDh5IN88US=>	NVLDfJBYW0GQR1XS
NB5	NU\3WFM6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NUTpR3RnUUN3ME2wMlAyQDlzIN88US=>	M36zZnNCVkeHUh?=
MZ7-mel	MlLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NE\4T4JKSzVyPUCuNFE6OzRizszN	MXjTRW5ITVJ?
BT-474	M1m3Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NEftXZBKSzVyPUCuNFE6PDNizszN	MoHsV2FPT0WU
OAW-28	NI\mUm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M4P2NmlEPTB;MD6wNVk2PiEQvF2=	MkS2V2FPT0WU
ES6	M1fHUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MUnJR\|UxRTBwMEKwNFgh\|ryP	MYHTRW5ITVJ?
PC-3	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXrJR\|UxRTBwMEKwN\|Yh\|ryP	NWnpS4M{W0GQR1XS
COR-L88	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3POOGlEPTB;MD6wNlA2PCEQvF2=	MlfXV2FPT0WU
D-392MG	NVO3OmhFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mo\tTWM2OD1yLkCyNFY5KM7:TR?=	MXXTRW5ITVJ?
LB2518-MEL	M{DOe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXWwSVE2UUN3ME2wMlAzOTZzIN88US=>	M2XmfHNCVkeHUh?=
LoVo	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MknLTWM2OD1yLkCyNVczKM7:TR?=	MUHTRW5ITVJ?
HCC1954	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXLJR\|UxRTBwMEKxPVIh\|ryP	MlPDV2FPT0WU
COLO-792	NWr4VFRmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NEOydXBKSzVyPUCuNFIyQTZizszN	Mmf4V2FPT0WU
KLE	NWT6fnhJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3rydWlEPTB;MD6wNlMzOyEQvF2=	MX3TRW5ITVJ?
MDA-MB-157	NE\D[pRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NWHJR2o6UUN3ME2wMlAzOzR7IN88US=>	MU\TRW5ITVJ?
PANC-08-13	M3\yVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFjXeWpKSzVyPUCuNFI1PjVizszN	NYnWO2x3W0GQR1XS
NCI-H727	Mmj4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoT6TWM2OD1yLkCyOFc1KM7:TR?=	NYXRNFlEW0GQR1XS
NCI-H1155	NEK0V2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHnxco9KSzVyPUCuNFI1PzdizszN	NGThPZNUSU6JRWK=
GCIY	NFzZV2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3zrV2lEPTB;MD6wNlUxOiEQvF2=	M3n4O3NCVkeHUh?=
MKN1	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2f6XmlEPTB;MD6wNlU4PiEQvF2=	MXHTRW5ITVJ?
NCI-H1092	MmD6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MkXVTWM2OD1yLkCyOlU1KM7:TR?=	MX3TRW5ITVJ?
RMG-I	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVXJR\|UxRTBwMEK3JO69VQ>?	MYLTRW5ITVJ?
NB12	MnXwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MVzJR\|UxRTBwMEK3NkDPxE1?	MorSV2FPT0WU
RCM-1	MmHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M2HWZ2lEPTB;MD6wNlgyQSEQvF2=	NXT2W5c4W0GQR1XS
C3A	NEi5bXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXjiT3ZmUUN3ME2wMlAzQDJ{IN88US=>	NUHRToQxW0GQR1XS
NCI-H747	NIPYcXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MkD2TWM2OD1yLkCyPFM4KM7:TR?=	NIHHNHlUSU6JRWK=
LB771-HNC	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NEHWSIhKSzVyPUCuNFI5OzdizszN	NX\qdnBwW0GQR1XS
EW-13	NYS0NZJYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NYX4eJRCUUN3ME2wMlAzQTB2IN88US=>	M1;q[nNCVkeHUh?=
CAL-72	NVTuRVhMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MmfDTWM2OD1yLkCyPVE5KM7:TR?=	MWjTRW5ITVJ?
HH	M4nycmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MV3JR\|UxRTBwMEK5PVgh\|ryP	MUPTRW5ITVJ?
UACC-257	NV7tTYVYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2fTS2lEPTB;MD6wN\|A{KM7:TR?=	MkXBV2FPT0WU
OAW-42	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYHJR\|UxRTBwMEOwN{DPxE1?	MYTTRW5ITVJ?
CAPAN-1	NIfXWlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NEDSW3BKSzVyPUCuNFMxPTJizszN	MV\TRW5ITVJ?
SNU-C2B	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NYH0OoNtUUN3ME2wMlA{ODZ\|IN88US=>	M2e1O3NCVkeHUh?=
NKM-1	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHLoNYxKSzVyPUCuNFMyPjlizszN	MkTFV2FPT0WU
GR-ST	NX7zSHNXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MnizTWM2OD1yLkCzNVg2KM7:TR?=	NWewS41UW0GQR1XS
SW1463	NXHOZWZMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NELPNWhKSzVyPUCuNFM{OzdizszN	NVKzOWVmW0GQR1XS
MEL-HO	M17Md2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVLJR\|UxRTBwMEO0NlEh\|ryP	MlT6V2FPT0WU
NCI-H2342	NIDhcoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M4DpT2lEPTB;MD6wN\|Y{OyEQvF2=	M3HkdnNCVkeHUh?=
ACHN	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3LNbGlEPTB;MD6wN\|cyKM7:TR?=	MofWV2FPT0WU
RH-18	NWfnZo9LT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MlPETWM2OD1yLkCzO\|Y{KM7:TR?=	MYnTRW5ITVJ?
HCC2218	NVvUTlJUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NFXVU2hKSzVyPUCuNFM4QSEQvF2=	Mli5V2FPT0WU
OS-RC-2	NXXLVVd[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIrYRnVKSzVyPUCuNFM5PjlizszN	NEHyRmtUSU6JRWK=
KP-N-YN	NHfJTZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHrQN5BKSzVyPUCuNFM5PzZizszN	M{Lkc3NCVkeHUh?=
COLO-668	NFjSU5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NG\nOHNKSzVyPUCuNFM5QDdizszN	NWS1V4ZZW0GQR1XS
LU-65	MnfCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NWm5T4VzUUN3ME2wMlA{QTB2IN88US=>	NX;XXlVRW0GQR1XS
NB6	M4S1bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NYXuV4hXUUN3ME2wMlA{QTV{IN88US=>	M1f4ZXNCVkeHUh?=
HT	NGX1RY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUTkN\|ZVUUN3ME2wMlA1ODB5IN88US=>	NVi4eY9VW0GQR1XS
COLO-684	M1e0Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYPJR\|UxRTBwMESwPVUh\|ryP	NXfNXI1WW0GQR1XS
NCI-H1693	NHvZfVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MmPDTWM2OD1yLkC0N\|A2KM7:TR?=	M{nMPXNCVkeHUh?=
LAN-6	M4Xud2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVXJR\|UxRTBwMESzN\|Uh\|ryP	M{OzZ3NCVkeHUh?=
MDA-MB-175-VII	NYHFdVVyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3T6XWlEPTB;MD6wOFQyPyEQvF2=	NVy2WmxYW0GQR1XS
KMOE-2	NYrHNZF2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MkXHTWM2OD1yLkC0OFY6KM7:TR?=	NWPRdldqW0GQR1XS
DMS-79	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NV;jd3dzUUN3ME2wMlA1PTd7IN88US=>	MXPTRW5ITVJ?
MHH-NB-11	NHXWVIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NFi1T3ZKSzVyPUCuNFQ3OTRizszN	MmXVV2FPT0WU
NCI-H69	NHHPcGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MkX0TWM2OD1yLkC0PFQ6KM7:TR?=	M2DUdXNCVkeHUh?=
KE-37	NFzRdlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{PxT2lEPTB;MD6wOVAyKM7:TR?=	M3zSeXNCVkeHUh?=
Ramos-2G6-4C10	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NE\WVZJKSzVyPUCuNFUxPjdizszN	MVrTRW5ITVJ?
NCI-H1793	NHXCdGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NWDEe2tEUUN3ME2wMlA2ODl\|IN88US=>	MnLsV2FPT0WU
HT-1376	M{\5SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1jGUGlEPTB;MD6wOVE5PiEQvF2=	MkXlV2FPT0WU
EKVX	M{jEWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M4PjfGlEPTB;MD6wOVM5PCEQvF2=	NXXBOGhqW0GQR1XS
Capan-2	Mn[yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1TFcWlEPTB;MD6wOVM6PiEQvF2=	M2LMNHNCVkeHUh?=
DoTc2-4510	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3TNdWlEPTB;MD6wOVQ1PiEQvF2=	MlrmV2FPT0WU
UACC-893	NWLX[VRTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1nIT2lEPTB;MD6wOVQ3OiEQvF2=	MlXtV2FPT0WU
SK-MEL-3	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXPJR\|UxRTBwMEW3PFgh\|ryP	NGW3W5VUSU6JRWK=
SK-MEL-1	NEnzO3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{f1d2lEPTB;MD6wOVgh\|ryP	M3XhSXNCVkeHUh?=
SW948	M3XHeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MmG3TWM2OD1yLkC1PVk3KM7:TR?=	MoLpV2FPT0WU
P30-OHK	NHjMNmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MYjJR\|UxRTBwME[xOlch\|ryP	MkDSV2FPT0WU
NH-12	NILJbHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXXSdZV7UUN3ME2wMlA3OjR2IN88US=>	NV3yN4VGW0GQR1XS
KU-19-19	NFO5UlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mm[zTWM2OD1yLkC2N\|YyKM7:TR?=	NYHXV28{W0GQR1XS
A431	NFG5OolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NIS5ZllKSzVyPUCuNFY{PzRizszN	MUTTRW5ITVJ?
NCI-H2405	NV\kUXVjT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MXLJR\|UxRTBwME[zPFMh\|ryP	NFzDNIZUSU6JRWK=
KARPAS-299	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NYHxdoU6UUN3ME2wMlA3PTh{IN88US=>	MXLTRW5ITVJ?
BALL-1	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MV3JR\|UxRTBwME[2O\|Qh\|ryP	MmXEV2FPT0WU
KURAMOCHI	NUDNUnVQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NH63eIRKSzVyPUCuNFcxPzNizszN	MmfoV2FPT0WU
LS-1034	NVX0d\|VWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1;QRmlEPTB;MD6wO\|M3QSEQvF2=	M1z2UnNCVkeHUh?=
MFE-280	Mm[xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnTuTWM2OD1yLkC3OVM3KM7:TR?=	MXfTRW5ITVJ?
HOP-62	M2PRemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MkHRTWM2OD1yLkC3Olc3KM7:TR?=	MnXNV2FPT0WU
KG-1	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1jkUWlEPTB;MD6wO\|c5PyEQvF2=	NHOxOHNUSU6JRWK=
CW-2	NH3jRnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVHJR\|UxRTBwMEe4N\|Ih\|ryP	MVjTRW5ITVJ?
SW837	Mn3oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Mo\xTWM2OD1yLkC4N\|QzKM7:TR?=	MkTsV2FPT0WU
MFH-ino	NHTNVldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NXTFNFZSUUN3ME2wMlA5PTBzIN88US=>	MUDTRW5ITVJ?
HCC1419	NELjW4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Ml\0TWM2OD1yLkC4PVg4KM7:TR?=	MVrTRW5ITVJ?
HMV-II	M2DSTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MULJR\|UxRTBwMEmwNUDPxE1?	NXnRcpFqW0GQR1XS
BEN	NXfi[2ZoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M33BeWlEPTB;MD6wPVM5PSEQvF2=	MYnTRW5ITVJ?
SK-N-FI	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Ml;0TWM2OD1yLkC5OVU3KM7:TR?=	NX7IT4NiW0GQR1XS
JVM-2	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVPJR\|UxRTBwMEm3NVYh\|ryP	NHvTZ5FUSU6JRWK=
CAL-54	NULwcJZ{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MlG2TWM2OD1yLkGwNFQh\|ryP	NHSzRpNUSU6JRWK=
T84	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M1XQXGlEPTB;MD6xNFk2OiEQvF2=	NGOxUHlUSU6JRWK=
SHP-77	M1u2fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NGr4ZXVKSzVyPUCuNVE3PDFizszN	M3KxVnNCVkeHUh?=
G-361	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3XmVGlEPTB;MD6xNlMzPCEQvF2=	M3nG[XNCVkeHUh?=
Calu-3	M1Ljb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXXJR\|UxRTBwMUO4NVYh\|ryP	NWPacnhVW0GQR1XS
HCC1937	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2q1NWlEPTB;MD6xOFk{PyEQvF2=	MnrtV2FPT0WU
KM-H2	NWLZUI9OT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXv5TowzUUN3ME2wMlE2ODFizszN	MU\TRW5ITVJ?
769-P	NF\uRmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MXPJR\|UxRTBwMUW4OFMh\|ryP	MmTtV2FPT0WU
NCI-H1304	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVLJR\|UxRTBwMU[wOlEh\|ryP	MlzZV2FPT0WU
D-542MG	NX\Dd4NjT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NFXyXVJKSzVyPUCuNVYzPzhizszN	NXu3UWxJW0GQR1XS
ATN-1	NYr0WZg6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MnPqTWM2OD1yLkG3OFQyKM7:TR?=	M4fDNnNCVkeHUh?=
NCI-H2029	NHjCWJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M13xNGlEPTB;MD6yNFI1OyEQvF2=	NVL6eJJWW0GQR1XS
ZR-75-30	MmHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NEmyUHZKSzVyPUCuNlA3PDNizszN	MWXTRW5ITVJ?
SW1116	M{LjZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MYfJR\|UxRTBwMkGxNVch\|ryP	NFXTS2tUSU6JRWK=
CCRF-CEM	NVW0XoE1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NFnKN4VKSzVyPUCuNlc3OTRizszN	MVPTRW5ITVJ?
LU-135	Mn7NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGPSe2dKSzVyPUCuNlc4OzlizszN	NGC2d\|lUSU6JRWK=
MC116	NIXyelFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MlzUTWM2OD1yLkK4N\|A6KM7:TR?=	M{m0fnNCVkeHUh?=
LS-513	M4nYR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnHhTWM2OD1yLkK4O\|c{KM7:TR?=	MXLTRW5ITVJ?
NCI-H630	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Ml3UTWM2OD1yLkK5N\|c3KM7:TR?=	NGOxblBUSU6JRWK=
L-428	MoriS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFHJWFVKSzVyPUCuNlk5QDNizszN	MU\TRW5ITVJ?
UM-UC-3	NUnYWWpHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NITOcW1KSzVyPUCuN\|EzQTFizszN	M2fIcnNCVkeHUh?=
NCI-H1838	NYTEcm9TT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MX\JR\|UxRTBwM{G3PFQh\|ryP	MUHTRW5ITVJ?
HEL	NITvclRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MUDJR\|UxRTBwM{KyOEDPxE1?	M1v1cnNCVkeHUh?=
OCI-AML2	NXnVbGNZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M4DFT2lEPTB;MD6zNlI6QCEQvF2=	NGfremhUSU6JRWK=
A3-KAW	M3noTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MWfJR\|UxRTBwM{O0O\|ch\|ryP	M{H0O3NCVkeHUh?=
IGROV-1	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NIm3OnpKSzVyPUCuN\|M4PTVizszN	M2jnR3NCVkeHUh?=
Mo-T	M{HMNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NW\ENGxSUUN3ME2wMlM{QDV\|IN88US=>	MU\TRW5ITVJ?
HDLM-2	NFOxdnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MUXJR\|UxRTBwM{O5JO69VQ>?	NH\nb5hUSU6JRWK=
HCC1569	MmjTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NIfmcYlKSzVyPUCuN\|Q{ODlizszN	NH\YXIhUSU6JRWK=
COLO-678	NXP3OYlbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MljPTWM2OD1yLkO3NFAzKM7:TR?=	NVP5W25VW0GQR1XS
COR-L105	M3r1U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVzJR\|UxRTBwM{e5N{DPxE1?	NUnBZ\|JoW0GQR1XS
SK-MEL-24	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2LKS2lEPTB;MD6zPFM5OiEQvF2=	M4PhOHNCVkeHUh?=
COLO-320-HSR	MkmwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MmfFTWM2OD1yLkSzPVc3KM7:TR?=	NFflcldUSU6JRWK=
C8166	MlvpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoP1TWM2OD1yLkS5NFI{KM7:TR?=	NGXRVW9USU6JRWK=
COLO-679	NXXTcFdlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2rId2lEPTB;MD62NlE4OiEQvF2=	M4fP[HNCVkeHUh?=
TE-12	NXGxSm83T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mn[5TWM2OD1yLk[1N\|k1KM7:TR?=	MlPDV2FPT0WU
HAL-01	NVOyU4oxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NWfkfFR4UUN3ME2wMlY3OjJizszN	MnTiV2FPT0WU
H-EMC-SS	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3Wzb2lEPTB;MD63NFU1PiEQvF2=	Mm[yV2FPT0WU
SNU-449	NE\pPIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVz6U3J{UUN3ME2wMlczPzR6IN88US=>	MW\TRW5ITVJ?
C32	NYexeFdCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MVPJR\|UxRTBwN{SxNVIh\|ryP	M1PJZXNCVkeHUh?=
K-562	NHT2Z5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVzJR\|UxRTBwN{ewNlQh\|ryP	MmXyV2FPT0WU
DJM-1	M17BNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NH24c\|VKSzVyPUCuO\|g4QDFizszN	NHjmSIdUSU6JRWK=
RCC10RGB	NXHSW2NNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1nXeGlEPTB;MD63PVE5OyEQvF2=	NHjyNmlUSU6JRWK=
CAL-85-1	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MlvLTWM2OD1yLkmwO{DPxE1?	NGXJZ2JUSU6JRWK=
NY	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MUDJR\|UxRTBwOUOzOVIh\|ryP	MW\TRW5ITVJ?
NCI-H1993	NH7GWVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MmKwTWM2OD1zLkG5Nlg6KM7:TR?=	NEK1[5JUSU6JRWK=
SK-OV-3	MnTtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVy5eY9EUUN3ME2xMlIzODh7IN88US=>	M33GNnNCVkeHUh?=

... Click to View More Cell Line Experimental Data

In vivo

Docetaxel (33 mg/kg/dose, given i.v. every 4 days for 3 injections) results in a tumor growth delay of 19.3 days in M2OL2 colon xenografts. Docetaxel also shows great antitumor activities in MX-1, SK-MEL-2, LX-1 and OVCAR-3 xenografts. Docetaxel inhibits the angiogenic response to fibroblast growth factor 2 with IC 50 of 5.4 mg/kg when injected twice weekly over a 14-day period, and angiogenesis is completely blocked in mice that receives 10 mg/kg Docetaxel. Docetaxel has selectivity for endothelial cell migration and/or microvessel formation because infiltration of inflammatory cells into the Matrigel plug is much less sensitive to inhibition by Docetaxel. ^[7]

Protocol

Cell Research:^[5]	+ Expand Cell lines: Human gastric cancer cell lines MKN-28 Concentrations: 6 nM Incubation Time: 3 days Method: 2000 cells in 180 μL of medium are seeded in a 96-well plate, and 20 μL of drug solution is simultaneously added in triplicate to each well. The plate is incubated for 3 days at 37°C in a humidified atmosphere of 5% CO₂. On day 3, 25 μL of MTT reagent is added to each well. After 4 h of incubation, the medium is removed by aspiration. 0.2 mL of dimethylsulphoxide (DMSO) is added to each well and thoroughly mixed by using a mechanical plate mixer to dissolve the resulting MTT-formazan crystals. Absorbance at 540 nm (OD) is measured by a reader. (Only for Reference)
Animal Research:^[6]	+ Expand Animal Models: Human colon carcinomas xenografts CX-1 Formulation: 50 mg/mL stock solution in ethanol by adding an equal volume of polysorbate 80 and diluting with 5% dextrose in water to the final volume Dosages: 33 mg/kg Administration: i.v. every 4 days for 3 injections (Only for Reference)

Cell Research:^[5]

+ Expand

Cell lines: Human gastric cancer cell lines MKN-28
Concentrations: 6 nM
Incubation Time: 3 days
Method: 2000 cells in 180 μL of medium are seeded in a 96-well plate, and 20 μL of drug solution is simultaneously added in triplicate to each well. The plate is incubated for 3 days at 37°C in a humidified atmosphere of 5% CO₂. On day 3, 25 μL of MTT reagent is added to each well. After 4 h of incubation, the medium is removed by aspiration. 0.2 mL of dimethylsulphoxide (DMSO) is added to each well and thoroughly mixed by using a mechanical plate mixer to dissolve the resulting MTT-formazan crystals. Absorbance at 540 nm (OD) is measured by a reader.
(Only for Reference)

Animal Research:^[6]

+ Expand

Animal Models: Human colon carcinomas xenografts CX-1
Formulation: 50 mg/mL stock solution in ethanol by adding an equal volume of polysorbate 80 and diluting with 5% dextrose in water to the final volume
Dosages: 33 mg/kg
Administration: i.v. every 4 days for 3 injections
(Only for Reference)

References

+ Expand

Solubility (25°C)

In vitro	DMSO	100 mg/mL (123.78 mM)
	Ethanol	53 mg/mL warmed (65.6 mM)
	Water	Insoluble
In vivo	Add solvents to the product individually and in order(Data is from Selleck tests instead of citations): 5% DMSO+30% PEG 300+5% Tween 80+ddH2O For best results, use promptly after mixing.	2mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information Download Docetaxel SDF

Molecular Weight	807.88
Formula	C₄₃H₅₃NO₁₄
CAS No.	114977-28-5
Storage	3 years -20°C powder
Storage	2 years -80°C in solvent
Synonyms	RP56976, NSC 628503

Bio Calculators

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

Serial Dilutions
Concertration (start):
Dilution-folds:

Computed Result

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2018-10-19)

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT03449901	Recruiting	Soft Tissue Sarcoma	Washington University School of Medicine\|Polaris Pharmaceuticals Inc.	May 9 2018	Phase 2
NCT02485691	Recruiting	Prostate Cancer Metastatic	Sanofi	November 9 2015	Phase 4
NCT01868022	Completed	Neoplasms	GlaxoSmithKline	October 9 2013	Phase 1
NCT01905657	Active not recruiting	Non Small Cell Lung Cancer (NSCLC)	Merck Sharp & Dohme Corp.	August 9 2013	Phase 2\|Phase 3
NCT01695135	Completed	Prostate Neoplasms	Janssen Research & Development LLC	August 9 2012	Phase 3
NCT03419234	Recruiting	Castration Levels of Testosterone\|Castration-Resistant Prostate Carcinoma\|Metastatic Prostate Carcinoma in the Soft Tissue\|Prostate Carcinoma Metastatic in the Bone\|Stage IV Prostate Adenocarcinoma AJCC v7	ECOG-ACRIN Cancer Research Group\|National Cancer Institute (NCI)\|Eastern Cooperative Oncology Group	February 8 2018	Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Microtubule Associated Signaling Pathway Map

Related Microtubule Associated Products

TAI-1 ^New

TAI-1 is a potent and specific Hec1 inhibitor, which disrupts Hec1-Nek2 protein interaction.
Docetaxel Trihydrate ^New

Docetaxel, an analog of paclitaxel, is an inhibitor of depolymerisation of microtubules by binding to stabilized microtubules.
Combretastatin A4 ^New

Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin with K_d of 0.4 μM.Phase 3.
Paclitaxel

Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.
Vincristine sulfate

Vincristine sulfate is an inhibitor of polymerization of microtubules by binding to tubulin with IC50 of 32 μM in a cell-free assay.
Nocodazole

Nocodazole is a rapidly-reversible inhibitor of microtubule polymerization, also inhibits Abl, Abl(E255K) and Abl(T315I) with IC50 of 0.21 μM, 0.53 μM and 0.64 μM in cell-free assays, respectively. Nocodazole improves the CRISPR-mediated HDR efficiency and has an additive effect on enhancing precise genome editing.
Vinorelbine Tartrate

Vinorelbine Tartrate is a semi-synthetic vinca alkaloid, and inhibits mitosis through interaction with tubulin.
Cabazitaxel

Cabazitaxel is a semi-synthetic derivative of a natural taxoid that kills cancer cells by inhibiting cell division and growth. Cabazitaxel exerts its effects by inhibiting microtubule growth and assembly, processes that are essential for cells to divide.

Features:A semi-synthetic derivative of a natural taxoid.
Patupilone (EPO906, Epothilone B)

Patupilone (EPO906, Epothilone B) is a paclitaxel-like microtubule-stabilizing agent with EC_0.01 of 1.8 μM. Phase 2.

Choose Your Country or Region

By Signaling Pathways

By product type

Docetaxel